Back to Newsroom

Catalyst Pharmaceuticals to Present at Rodman & Renshaw’s 18th Annual Global Investment Conference

CORAL GABLES, Fla., Sept. 08, 2016 (GLOBE NEWSWIRE) — Catalyst Pharmaceuticals, Inc. (Catalyst) (Nasdaq:CPRX), a biopharmaceutical company focused on developing and commercializing innovative therapies for people with rare debilitating diseases, today announced that Patrick J. McEnany, Chief Executive Officer, and Steven Miller, Ph.D., Chief Operating Officer and Chief Scientific Officer, will be presenting at Rodman & Renshaw’s 18thAnnual Global Investment Conference, which is being held on September 12-13, 2016 at the New York Palace Hotel in New York.

The presentation will occur on Monday, September 12th at 10:25 AM ET. The presentation materials will be posted at www.catalystpharma.com in the Investor section under Events and Presentations.

Click here to read the full release